NBP607-Y

NBP607-Y is a trivalent inactivated cell culture-derived influenza vaccine developed for the prevention of seasonal influenza. It is designed to induce immunity against three influenza virus strains (two subtype A and one type B), following annual recommendations by health authorities. The vaccine is produced using cell culture technology rather than traditional egg-based methods, which can offer advantages in scalability and allergen avoidance. Clinical trials have demonstrated that NBP607-Y is well tolerated and immunogenic in both adults and children[1][2]. Its mechanism of action involves stimulating the immune system to produce protective antibodies against the included influenza strains.

Brand names

SKYCellflu

Other names

Trivalent Inactivated Cell Culture-derived Influenza VaccineCell Culture flu Trivalent NDCKSKY Cellflu prefilled syringe